Secretases as targets for drug design in Alzheimer's disease

European Journal of Clinical Investigation

Volumn 32, Issue 1, 2002, Pages 60-68

  Hendriksen, J V R B ^a   Nottet, H S L M ^a   Smits, H A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Alzheimer's disease; Amyloid ; BACE; Presenilins; Secretases

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; GAMMA SECRETASE;

ALZHEIMER DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DEMENTIA; DRUG DESIGN; DRUG TARGETING; HUMAN; MOLECULAR MECHANICS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; DRUG DESIGN; ENDOPEPTIDASES; HUMANS;

EID: 0037003505     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.00937.x     Document Type: Conference Paper

References (103)

1. Selkoe DJ. Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci 1994;17:489-517.
2. Iwatsubo T, Mann DMA, Odaka A, Suzuki N, Ihara Y. Amyloid β protein (Aβ) deposition: aβ42(43) precedes Aβ40 in Down syndrome. Ann Neurol 1995;37:294-9.
3. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biophys Res Commun 1984;120:885-90.
4. Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido T et al. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nature Med 1996;2:1146-50.
5. Burdick D, Soreghan B, Kwon M, Kosomoski J, Knauer M, Henschen A et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem 1992;267:546-54.
6. Jarett JT, Berger EP, Lansbury PT. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochem 1993;32:4693-7.
7. Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991;12:383-8.
8. Kang J, Lemaire H-G, Unterbech A, Alsboum M, Masters CL et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:733-6.
9. Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk Det al. The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nature Med 1995;1:1291-6.
10. Thinakaran G, Teplow DB, Siman R, Greenberg B, Sisoda SS. Metabolism of the 'Swedish' amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the 'beta-secretase' site occurs in the golgi apparatus. J Biol Chem 1996;271:9390-7.
11. Perez RG, Soriano S, Hayes JD, Ostaszewski B, Xia W, Selkoe DJ et al. Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J Biol Chem 1999;274:18851-6.
12. Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 1996;357:500-3.
13. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999;286:735-41.
14. Haass C, Selkoe DJ. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell 1993;75:1039-42.
15. Dovey HF, Suomesaari-Chrysler S, Lieberburg I, Shinha S, Kiem PS. Cells with a familial Alzheimer's disease mutation produce authentic β-peptide. Neuroreport 1993;4:1039-42.
16. Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk DB. Characterization of β amyloid peptide from human cerebrospinal fluid. J Neurochem 1993;61:19965-8.
17. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K. Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. Mol Biol 1991;218:149-63.
18. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A et al. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J Biol Chem 1992;267:546-54.
19. Jarrett JT, Lansbury PT Jr. Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993;73:1055-8.
20. De Strooper B, Umans L, van Leuven F, van den Berghe H. Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway. J Cell Biol 1993;121:295-304.
21. Kuentzel S, Ali S, Altman R, Greenberg B, Raub T. The Alzheimer beta-amyloid protein precursor/protease nexin-II is cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells. Biochem J 1993;295:367-78.
22. Sambamurti K, Shioi J, Anderson JP, Pappolla MA, Rabakis N. Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells. J Neurosci Res 1992;33:319-29.
23. Sisodia SS. Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci USA 1992;89:6075-9.
24. Koo EH, Squazzo S. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 1994;269:17386-9.
25. Skovronsky DM, Moore DB, Milla ME, Doms RW, Lee VM. Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. J Biol Chem 2000;275:2568-75.
26. Weidemann A, König G, Bunke D, Fischer P, Salbaum JM, Masters Cet al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 1989;57:115-126.
27. Olterdorf T, Ward PJ, Hendriksson T, Beattie EC, Neve R, Lieberburg Iet al. The Alzheimer amyloid precursor protein: Identification of a stable intermediate in the biosynthetic/ degradative pathway. Biol Chem 1990;265:4492-7.
28. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR et al. Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science 1990;248:1122-4.
29. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 1990;248:492-5.
30. Slack BE, Ma LK, Seah CC. Constitutive shedding of the amyloid-precursor protein ectodomain is up-regulated by tumor necrosis factor-alpha converting enzyme. Biochem J 2001;357:787-94.
31. Itai T, Tanaka M, Nagata S. Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form. Eur J Biochem 2001;268:2074-82.
32. Lopez-Perez E, Zhang Y, Frank SJ, Creemers J, Seidah N, Checler F. Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10. J Neurochem 2001;76:1532-9.
33. Nunan J, Small DH. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett 2000;483:6-10.
34. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 1992;359:322-35.
35. Haas C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ. β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 1993;268:3021-4.
36. Lendon CL, Ashall F, Goate AM. Exploring the etiology of Alzheimer disease using molecular genetics. J AM Med Assoc 1997;277:825-31.
37. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Proc Natl Acad Sci USA 1995;92:4725-7.
38. Fraser PE, Yang D-S, Yu G, Lévesque L, Nishimura M, Arawaka Set al. Presenilin structure, function and role in Alzheimer's disease. Biochim Biophys Acta 2000;1502:1-15.
39. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW et al. Gene dose of apolipoprotein-E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
40. Cai X-D, Golde TE, Younkin SG. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 1993;259:514-16.
41. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert Pet al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 1992;360:672-4.
42. Suzuki N, Cheung TT, Cai X-D, Odaka A, Otvos L Jr, Eckman Cet al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP. 717) mutants. Science 1994;264:1336-40.
43. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L et al. Segregation of a missense mutation in the mayloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-6.
44. Chartier-Harlin M-C, Crawford F, Houlden H, Warren A, Hughes D, Fidani L et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991;353:844-6.
45. Murrell J, Farlow M, Ghetti B, Benson MD. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 1991;254:97-9.
46. Karlinsky H, Vaula G, Haines JL, Ridgley J, Bergeron C, Mortilla M et al. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the beta-amyloid precursor protein gene. Neurology 1992;42:1445-53.
47. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-75.
48. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-8.
49. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-7.
50. Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992;258:668-71.
51. St George-Hyslop P, Haines PH, Rogaev E, Mortilla M, Vaula G, Pericak-Vance M et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet 1992;2:330-4.
52. Van Broeckhoven C, Backhovens H, Cruts M, De Winter G, Bruyland M, Cras P et al. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24. 3 Nat Genet 1992;2:335-9.
53. Wisniewski T, Dowjat WK, Buxbaum JD, Khorkova O, Efthimiopoulos S, Kulczycki J et al. A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. Neuroreport 1998;9:217-21.
54. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 1996;2:864-70.
55. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley MM et al. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity. Nature 1999;402:53-7.
56. Shinha S, Anderson JP, Barbour R, Basi Gs, Caccavello R, Davis D et al. Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature 1999;402:537-40.
57. Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C et al. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci 1999;14:419-27.
58. Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci USA 2000;97:1456-60.
59. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P et al. Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation. Nat Neurosci 2001;4:231-2.
60. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL et al. BACE is the major β-secretase for generation of Aβ peptides by neurons. Nat Neurosci 2001;4:233-4.
61. Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS et al. BACE knockout mice are healthy despite lacking the primary-secretase activity in the brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet 2001;10:1317-24.
62. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 1996;17:181-90.
63. Doan A, Thinakaran G, Borchelt DR, Slunt HH, Ratovitsky T, Podlisny M et al. Protein topology of presenilin 1. Neuron 1996;17:1023-30.
64. Lehmann S, Chiesa R, Harris DA. Evidence for a six-transmembrane domain structure of presenilin 1. J Biol Chem 1997;272:12047-51.
65. De Strooper B, Beullens M, Contreras B, Levesque L, Craessaerts K, Cordell B et al. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J Biol Chem 1997;272:3590-8.
66. Podlisny MB, Citron M, Amarante P, Sherrington R, Xia W, Zhang J et al. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol Dis 1997;3:325-37.
67. Seeger M, Nordstedt C, Petanceska S, Kovacs DM, Gouras GK, Hahne S et al. Evidence for phosphorylation and oligomeric assembly of presenilin 1. Proc Natl Acad Sci USA 1997;94:5090-4.
68. Capell A, Grünberg J, Pesold B, Diehlmann A, Citron M, Nixon R et al. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J Biol Chem 1998;273:3205-11.
69. Yu G, Ghen F, Levesque G, Nishimura M, Zhang D-M, Levesque L et al. The presenilin 1 protein is a component of a high molecular weight complex that contains β-catenin. J Biol Chem 1998;273:16470-5.
70. Li Y-M, Lai M-T, Xu M, Huang Q, DiMuzio-Mower J, Sardana MK et al. Presenilin-1 is linked with γ-secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA 2000;97:6138-43.
71. Kim TW, Pettingell WH, Hallmark OG, Moir RD, Wasco W, Tanzi RE. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J Biol Chem 1997;272:1006-10.
72. Steiner H, Capell A, Pesold B, Citron M, Kloetzel PM, Selkoe DJ et al. Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. J Biol Chem 1998;273:32322-31.
73. Thinakaran G, Harris CL, Ratovitski T, Davenport F, Slunt HH, Price DL et al. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J Biol Chem 1997;272:28415-22.
74. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998;391:387-90.
75. Mumm JS, Kopan R. Notch signaling: From the outside in. Dev Biol 2000;228:151-65.
76. Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, Pan DJ et al. A ligand-induced extracellular cleavage regulates γ-secretase-like proteolytic activation of Notch 1. Mol Cell 2000;5:197-206.
77. Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 1998;393:382-6.
78. Steiner H, Duff K, Capell A, Romig H, Grim MG, Lincoln S et al. A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling. J Biol Chem 1999;274:28669-73.
79. Herreman A, Hartmann D, Annaert W, Saftig P, Craessaerts K, Serneels L et al. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci USA 1999;96:11872-7.
80. Struhl G, Adachi A. Requirements for presenilin-dependent cleavage of Notch and other transmembrane proteins. Mol Cell 2000;6:625-36.
81. Wolfe MS, Xia W, Moore CL, Leatherwood DD, Ostaszewski B, Rahmati T et al. Peptidomimetic probes and molecular modeling suggest that Alzheimer's γ-secretase is an intramembrane-cleaving aspartyl protease. Biochem 1999;38:4720-7.
82. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Taylor Kimberly W, Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nat Cell Biol 1999;398:513-17.
83. Esler WP, Kimberly WT, Ostaszewski BL, Diehl TS, Moore CL, Tsai J-Y et al. Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1. Nat Cell Biol 2000;2:428-34.
84. Li Y-M, Xu M, Lai M-T, Huang Q, Castro JL, DiMuzio-Mower J et al. Photoactivatedg-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 2000;405:689-94.
85. Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing. Nature 2000;407:48-54.
86. Zubenko GS, Hughes HB, Stiffler JS, Hurtt MR, Kaplan BB. A genome survey for novel Alzheimer disease risk loci: results at 10 cM resolution. Genomics 1998;50:121-8.
87. Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I, et al. A full genome scan for late onset Alzheimer's Disease. Hum Mol Gen 1999;8:237-45.
88. Kovacs DM, Fausett HJ, Page KJ, Kim T-W, Moir RD, Merriam DE et al. Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med 1996;2:224-9.
89. Walter J, Capell A, Grunberg J, Pesold B, Schindzielorz A, Prior R et al. The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol Med 1996;2:673-91.
90. Capell A, Saffrich R, Olivo JC, Meyn L, Walter J, Grunberg J et al. Cellular expression and proteolytic processing of presenilin proteins is developmentally regulated during neuronal differentiation. J Neurochem 1997;69:2432-40.
91. Kopan R, Schroeter EH, Weintraub H, Nye JS. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci USA 1996;93:1683-8.
92. Ray WJ, Tao M, Mumm J, Schroeter EH, Saftig P, Wolfe M et al. Cell surface presenilin-1 participates in the γ-secretase-like proteolysis of Notch. J Biol Chem 1999;274:36801-7.
93. Schwarzman AL, Singh N, Tsiper M, Gregori L, Dranovsky A, Vitek MP et al. Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix. Proc Natl Acad Sci USA 1999;96:7932-7.
94. Kimberly WT, Xia W, Rahmati T, Wolfe MS, Selkoe DJ. The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation. J Biol Chem 2000;275:3173-8.
95. Capell A, Steiner H, Romig H, Keck S, Baader M, Grim MG et al. Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch. Nat Cell Biol 2000;2:205-10.
96. Steiner H, Kastka M, Romig H, Basset G, Pesold B, Hardy J et al. Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases. Nat Cell Biol 2000;2:848-51.
97. Lichtenthaler SF, Wang R, Grimm H, Uljon SN, Masters CL, Beyreuther K. Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein. Proc Natl Acad Sci USA 1999;96:3053-8.
98. Vassar R, Citron M. Aβ-generating enzymes: Recent advances in β- and γ-secretase research. Neuron 2000;27:419-22.
99. Baumeister R, Leimer U, Zweckbronner I, Jakubek C, Grünberg J, Haas C. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes Funct 1997;1:149-59.
100. Levitan D, Doyle TG, Brousseau D, Lee MK, Thinakaran G, Slunt HH, et al. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc Natl Acad Sci USA 1996;93:14940-4.
101. Struhl G, Adachi A. Nuclear access and action of notch in vivo. Cell 1998;93:649-60.
102. Selkoe DJ. Translating cell biology into therapeuric advances in Alzheimer's disease. Nature 1999;399:A23-31.
103. Urbanc B, Cruz L, Buldyrev SV, Havlin S, Irizarry MC, Stanley HE et al. Dynamics of plaque formation in Alzheimer's disease. Biophys J 1999;76:1330-4.